Nordic Nanovector



Nordic Nanovector is committed to developing and delivering innovative therapies to patients to address major unmet medical needs. The Company aspires to become a leader in the development of CD37-targeted therapies for hematological cancers and immune diseases.


Add photos to showcase Nordic Nanovector’s culture


Add Nordic Nanovector’s values

Insider experiences

Share your experience of working at Nordic Nanovector

Jostein Dahle
Co-Founder & Chief Scientific Officer
Pierre Dodion
Chief Medical Officer
Gabriele Elbl
VP, Global Regulatory Affairs

Add your teams to show how people work together at Nordic Nanovector

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.